LOBO EV Technologies Ltd. and Roundtree Lab Strengthen Partnership as Roundtree Initiates HIPAA Compliance for Smart Medical Beds
March 19 2025 - 9:30AM
LOBO EV Technologies Ltd. (Nasdaq: LOBO) (“LOBO” or the “Company”),
an innovative designer and manufacturer of e-mobility and
AI-powered solutions, and Roundtree Lab, LLC (“Roundtree”), a
leader in AI-driven healthcare innovations, today announced the
next phase of their strategic partnership: Roundtree’s initiation
of HIPAA compliance certification for the smart medical beds
produced under their exclusive manufacturing agreement.
This significant step reinforces the companies’ shared
commitment to data security, regulatory compliance, and enhanced
patient care as they prepare to introduce smart medical beds to
healthcare facilities across the United States. Achieving Health
Insurance Portability and Accountability Act (HIPAA) compliance
will ensure that sensitive patient information collected and
processed by the embedded smart technology remains secure and
adheres to U.S. healthcare regulations.
Key Highlights of This Next Phase
1. HIPAA Compliance for Smart
Medical Beds
Roundtree is initiating a comprehensive compliance framework to
align its smart technology with HIPAA privacy and security
regulations.
This ensures that electronic patient health information (ePHI)
handled by the smart medical beds meets strict U.S. regulatory
standards.
2. Advancing Market Readiness and
Adoption
HIPAA compliance will enable faster adoption of smart medical
beds in U.S. hospitals and healthcare facilities.
Compliance will also support partnerships with insurance
providers, government agencies, and healthcare networks that
require strict regulatory adherence.
3. Expanding LOBO’s Presence in
the Healthcare Sector
This milestone further solidifies LOBO’s strategic
diversification into the U.S. medical device market.
LOBO’s manufacturing expertise will be instrumental in
delivering secure, compliant, and intelligent patient transport
solutions to hospitals nationwide.
Management Commentary
LOBO CEO Huajian Xu emphasized the importance of this
initiative:
"Ensuring compliance with U.S. healthcare regulations is a
critical step in our journey to bring smart medical solutions to
the market. Roundtree’s commitment to HIPAA certification will
enable our smart medical beds to meet the highest security and
privacy standards, giving hospitals confidence in adopting this
transformative technology. This partnership continues to show
LOBO’s ability to expand beyond mobility solutions into smart
healthcare innovations. By combining our expertise in manufacturing
and AI-driven automation with Roundtree’s pioneering healthcare
solutions, we are creating a seamless, technology-driven approach
to patient care."
Roundtree CEO Gordon Franklin highlighted the strategic
significance of this step:
"Achieving HIPAA compliance is fundamental to integrating smart
healthcare solutions into the medical system. Patient data security
and regulatory adherence are crucial for the adoption of advanced
medical technologies, and we are fully committed to meeting these
standards. Our collaboration with LOBO is progressing rapidly, and
this next step brings us closer to revolutionizing patient
transport and care through intelligent smart medical beds. With
LOBO’s manufacturing excellence and our focus on AI-driven
healthcare innovation, we are set to make a lasting impact on the
U.S. healthcare industry."
Looking Ahead
With HIPAA certification underway, LOBO and Roundtree are
actively preparing for commercial deployment and large-scale
adoption of the smart medical beds. Following compliance approval,
the companies will focus on:
- Expanding distribution
channels across U.S. hospitals and healthcare
providers.
- Establishing strategic
partnerships with medical institutions and insurance
companies.
- Enhancing AI capabilities to
further optimize patient care and operational
efficiency.
About LOBO EV Technologies Ltd.
LOBO EV Technologies Ltd. (Nasdaq: LOBO) is an innovative
designer, developer, manufacturer, and seller of e-bicycles,
e-mopeds, e-tricycles, and electric off-highway four-wheeled
shuttles. The Company also specializes in AI-powered multimedia
interactive systems and is expanding into medical technology
manufacturing. By leveraging cutting-edge AI, connectivity, and
automation, LOBO aims to provide intelligent, efficient, and secure
mobility and healthcare solutions.
For more information, visit: https://www.loboebike.com and
https://loboev.io.
About Roundtree Lab, LLC
Roundtree Lab, LLC is a leader in AI-driven healthcare
solutions, specializing in smart medical devices and patient
transport innovations. By integrating artificial intelligence and
automation, Roundtree is committed to improving hospital
efficiency, patient safety, and healthcare operations.
Safe Harbor Statement
This press release contains forward-looking statements under the
U.S. Private Securities Litigation Reform Act of 1995. These
statements are based on the Company’s current expectations and
assumptions and are subject to risks and uncertainties. Actual
results may differ due to regulatory approvals, market conditions,
and other factors detailed in the Company’s filings with the U.S.
Securities and Exchange Commission (SEC). LOBO undertakes no
obligation to update these forward-looking statements unless
required by law.
For Investor and Media Inquiries, Please Contact:
HORIZON IR
Michael Wei
Email: hwey@horizonconsultancy.co
LOBO EV Technologies (NASDAQ:LOBO)
Historical Stock Chart
From Apr 2025 to May 2025
LOBO EV Technologies (NASDAQ:LOBO)
Historical Stock Chart
From May 2024 to May 2025